中国医药
中國醫藥
중국의약
CHINA MEDICINE
2008年
11期
659-662
,共4页
时昌文%赵霞%李杰%于振海%孙京杰%曹莉莉
時昌文%趙霞%李傑%于振海%孫京傑%曹莉莉
시창문%조하%리걸%우진해%손경걸%조리리
肝肿瘤%组蛋白脱乙酰酶抑制剂%丙戊酸钠
肝腫瘤%組蛋白脫乙酰酶抑製劑%丙戊痠鈉
간종류%조단백탈을선매억제제%병무산납
Hepatocellular carcinoma%Histone deacetylase inhibitor%Valproic acid sodium(VPA)
目的 观察应用组蛋白脱乙酰酶抑制剂丙戊酸钠调节染色体组蛋白低乙酰化水平对肝癌细胞增殖的作用,并进一步检测Cyclin A、Cyclin D1、Cychn E、P21 Waf/cip1蛋白及mRNA表达变化,探讨其分子作用机制.方法 应用0.75~4.0 mmol/L丙戊酸钠作用于肝癌细胞系HepG2细胞后,MTT法检测细胞生长抑制、细胞克隆形成试验观察克隆形成率、碘化丙啶标记流式细胞术检测细胞周期、间接免疫荧光法分析Cyclin A、Cyclin D1、Cyclin E、P21Waf/cip1蛋白表达,RT-PCR检测分析Cyclin A、Cyclin D1、Cyclin E、P21Waf/cip1mRNA表达.结果 0.75~4.0 mmol/L丙戊酸钠作用24、48、72、96 h,观察组出现了时间-剂量依赖趋势的生长抑制,同时细胞克隆形成率显著降低,对照组细胞增殖周期G1、S、M期所占比例未见明显改变,而观察组则随药物浓度、作用时间的不同而出现不同程度的细胞增殖周期G1期阻滞.Gl期比例由55.4%~82.8%不等,差异有统计学意义(P<0.01).观察组Cyclin A、Cyclin D1蛋白及mRNA表达均被明显下调而LP21Waf/cip1蛋白、mRNA表达则被明显上调,与对照组比较差异均有统计学意义(均P<0.01);而CyclinE蛋白和mRNA表达变化则未见明显差异(P>0.05).结论 通过应用特异性组蛋白脱乙酰酶抑制剂调节组蛋白乙酰化修饰可明显抑制肝癌细胞生长、抑制细胞克隆形成、阻滞细胞增殖周期于G1期;丙戊酸钠作为组蛋白脱乙酰酶抑制剂可明显抑制肝癌细胞增殖,其作用机制是通过上调P21Waf/cip1 mRNA蛋白表达,下调Cyclin D1、Cyclin A mRNA蛋白表达分别和/或协同实现.
目的 觀察應用組蛋白脫乙酰酶抑製劑丙戊痠鈉調節染色體組蛋白低乙酰化水平對肝癌細胞增殖的作用,併進一步檢測Cyclin A、Cyclin D1、Cychn E、P21 Waf/cip1蛋白及mRNA錶達變化,探討其分子作用機製.方法 應用0.75~4.0 mmol/L丙戊痠鈉作用于肝癌細胞繫HepG2細胞後,MTT法檢測細胞生長抑製、細胞剋隆形成試驗觀察剋隆形成率、碘化丙啶標記流式細胞術檢測細胞週期、間接免疫熒光法分析Cyclin A、Cyclin D1、Cyclin E、P21Waf/cip1蛋白錶達,RT-PCR檢測分析Cyclin A、Cyclin D1、Cyclin E、P21Waf/cip1mRNA錶達.結果 0.75~4.0 mmol/L丙戊痠鈉作用24、48、72、96 h,觀察組齣現瞭時間-劑量依賴趨勢的生長抑製,同時細胞剋隆形成率顯著降低,對照組細胞增殖週期G1、S、M期所佔比例未見明顯改變,而觀察組則隨藥物濃度、作用時間的不同而齣現不同程度的細胞增殖週期G1期阻滯.Gl期比例由55.4%~82.8%不等,差異有統計學意義(P<0.01).觀察組Cyclin A、Cyclin D1蛋白及mRNA錶達均被明顯下調而LP21Waf/cip1蛋白、mRNA錶達則被明顯上調,與對照組比較差異均有統計學意義(均P<0.01);而CyclinE蛋白和mRNA錶達變化則未見明顯差異(P>0.05).結論 通過應用特異性組蛋白脫乙酰酶抑製劑調節組蛋白乙酰化脩飾可明顯抑製肝癌細胞生長、抑製細胞剋隆形成、阻滯細胞增殖週期于G1期;丙戊痠鈉作為組蛋白脫乙酰酶抑製劑可明顯抑製肝癌細胞增殖,其作用機製是通過上調P21Waf/cip1 mRNA蛋白錶達,下調Cyclin D1、Cyclin A mRNA蛋白錶達分彆和/或協同實現.
목적 관찰응용조단백탈을선매억제제병무산납조절염색체조단백저을선화수평대간암세포증식적작용,병진일보검측Cyclin A、Cyclin D1、Cychn E、P21 Waf/cip1단백급mRNA표체변화,탐토기분자작용궤제.방법 응용0.75~4.0 mmol/L병무산납작용우간암세포계HepG2세포후,MTT법검측세포생장억제、세포극륭형성시험관찰극륭형성솔、전화병정표기류식세포술검측세포주기、간접면역형광법분석Cyclin A、Cyclin D1、Cyclin E、P21Waf/cip1단백표체,RT-PCR검측분석Cyclin A、Cyclin D1、Cyclin E、P21Waf/cip1mRNA표체.결과 0.75~4.0 mmol/L병무산납작용24、48、72、96 h,관찰조출현료시간-제량의뢰추세적생장억제,동시세포극륭형성솔현저강저,대조조세포증식주기G1、S、M기소점비례미견명현개변,이관찰조칙수약물농도、작용시간적불동이출현불동정도적세포증식주기G1기조체.Gl기비례유55.4%~82.8%불등,차이유통계학의의(P<0.01).관찰조Cyclin A、Cyclin D1단백급mRNA표체균피명현하조이LP21Waf/cip1단백、mRNA표체칙피명현상조,여대조조비교차이균유통계학의의(균P<0.01);이CyclinE단백화mRNA표체변화칙미견명현차이(P>0.05).결론 통과응용특이성조단백탈을선매억제제조절조단백을선화수식가명현억제간암세포생장、억제세포극륭형성、조체세포증식주기우G1기;병무산납작위조단백탈을선매억제제가명현억제간암세포증식,기작용궤제시통과상조P21Waf/cip1 mRNA단백표체,하조Cyclin D1、Cyclin A mRNA단백표체분별화/혹협동실현.
Objective To investigate the suppressing effect on hepatocellular carcinoma cell proliferation by up-regulating histone acetylizad level with a selective inhibitar of HDACs-Valproate acid sodium(VPA).And the mechanism which involved was clarified by detecting the protein and mRNA expressions of Cyclin A、Cyclin D1、Cyclin E、P21Walf/cipl.Methods HepG2 cells wero cultured with 0.75-4.0 mmol/L valproic acid(VPA)for 24,48,72,96hrs in vitro.The inhibition rate was studied by MTT assay:clone forming inhibit rate was tested by clonay assay;cell cycle was analyzed by flow cytometry with PI assay,and the protein and mRNA expressions of Cyclin A、Cydin D1、Cychn E、P21Waf/cip1 of HepG2 cells after 1.5.3.0 mmol/L VPA treated wero analyzed by indirect immunofluorescence technique and RT-PCR respectively.Results The inhibition rate of experimental group increased significantly(P<0.001)and a dose and acting time dependence was found.Clones in experimental groups decreased more than in control group.As for cell cycle,the percentage of G1,S,M phrase in control group remained the same.Compared with control group,0.75 and 4.0 mmol/L VPA induced a significant arrest in G1 phrase(P<0.001)and a total of 55.4%~82.8% G1 phrase of cells which cultured with VPA.Cychn A.Cyclin D1 were down-regulated both at mRNA and protein level(P<0.001)while P21Waf/cip1 was up-regulated both at mRNA and protein level.Conversely,neither mRNA nor protein expression of Cyclin E showed any difierence between experimental and control group(P>0.05).Conclusion Up-regulating histone acetylizad level can inhibit hepatocellular carcinoma cell proliferation,inhibit cell clone formation,induce cell cycle arrest in G1 phrase.VPA.as a Ⅰ class of histone deacetylase inhibitor can be used as an option in the treatment of hepetoma.The mechanism includes upregulating P21Waf/cip1 mRNA and protein expression,down-regulating Cyclin A,Cyclin D1 mRNA and protein expression.